UniPharma Co., Ltd. (6621.TWO)

TWD 13.85

(-0.72%)

Total Liabilities Summary of UniPharma Co., Ltd.

  • UniPharma Co., Ltd.'s latest annual total liabilities in 2023 was 37.4 Million TWD , up 27.51% from previous year.
  • UniPharma Co., Ltd.'s latest quarterly total liabilities in 2024 Q2 was 30.16 Million TWD , down 0.0% from previous quarter.
  • UniPharma Co., Ltd. reported annual total liabilities of 29.33 Million TWD in 2022, down -42.04% from previous year.
  • UniPharma Co., Ltd. reported annual total liabilities of 50.61 Million TWD in 2021, up 38.31% from previous year.
  • UniPharma Co., Ltd. reported quarterly total liabilities of 30.16 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • UniPharma Co., Ltd. reported quarterly total liabilities of 37.4 Million TWD for 2023 FY, up 27.51% from previous quarter.

Annual Total Liabilities Chart of UniPharma Co., Ltd. (2023 - 2019)

Historical Annual Total Liabilities of UniPharma Co., Ltd. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 37.4 Million TWD 27.51%
2022 29.33 Million TWD -42.04%
2021 50.61 Million TWD 38.31%
2020 36.59 Million TWD -33.39%
2019 54.93 Million TWD 0.0%

Peer Total Liabilities Comparison of UniPharma Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Allied Biotech Corporation 910.11 Million TWD 95.891%
GeneFerm Biotechnology Co., Ltd. 282.53 Million TWD 86.762%
Easywell Biomedicals, Inc. 589.98 Million TWD 93.661%
TTY Biopharm Company Limited 3.36 Billion TWD 98.89%
Synmosa Biopharma Corporation 3.62 Billion TWD 98.969%
Orient EuroPharma Co., Ltd. 6.64 Billion TWD 99.438%
Center Laboratories, Inc. 6.78 Billion TWD 99.449%
Tien Liang BioTech Co., Ltd. 161.05 Million TWD 76.777%
Orient Pharma Co., Ltd. 892.18 Million TWD 95.808%
InnoPharmax Inc. 48.64 Million TWD 23.121%
Johnson Chemical Pharmaceutical Works Co., Ltd. 320.99 Million TWD 88.348%
Excelsior Biopharma Inc. 472.87 Million TWD 92.091%
DV Biomed Co., Ltd. 765.87 Million TWD 95.117%
Foresee Pharmaceuticals Co., Ltd. 616.93 Million TWD 93.938%
Handa Pharmaceuticals, Inc. 280.88 Million TWD 86.684%
Anxo Pharmaceutical Co., Ltd. 1.01 Billion TWD 96.316%
Alar Pharmaceuticals Inc. 76.08 Million TWD 50.846%
Winston Medical Supply Co., Ltd. 373.87 Million TWD 89.996%
Mercury Biopharmaceutical Corporation 49.72 Million TWD 24.778%
Bioray Biotech Co., Ltd 108.75 Million TWD 65.609%
TSH Biopharm Corporation Limited 133.62 Million TWD 72.011%